drugset

drugset / Trial / NCT04299503

Topical Crisaborole in Patients with Alopecia Areata

NCT04299503 ↗

Phase 2 Withdrawn Tufts Medical Center

RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of this study is to determine whether topical crisaborole improves hair growth in alopecia areata.

Timeline

Start: 2020-03-06
Primary completion: 2022-03
Completion: 2022-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Crisaborole	Small molecule	2 %	Topical

Indications